BackF-star Therapeutics Overview

F-star Therapeutics Current Assets

F-star Therapeutics's current assets is $50M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$49.61M
34.86% YoYΔ $-26.55M vs prior year quarter

Peer average / median

Loading

F-star Therapeutics Current Assets History

Loading

F-star Therapeutics vs. peers: Current Assets Comparison

Loading

F-star Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

F-star Therapeutics (FSTX) FAQ

As of the most recent data (September 2022), FSTX shows a current assets of $50M. That compares with $76M in the prior-year period — down 34.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FSTX's current assets is now $50M (was $76M) — a 34.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether F-star Therapeutics is outperforming or lagging.

Tracking FSTX's current assets over time shows whether F-star Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $50M That compares with $76M in the prior-year period — down 34.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has F-star Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $50M) with ownership activity and broader fundamentals.

F-star Therapeutics's current assets is $50M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.